Hubbell Other Non-Current Liabilities increased by 0.1% to $826.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.8%, from $667.60M to $826.50M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 6.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $125.90M | $125.40M | $521.30M | $547.10M | $530.70M | $508.40M | $505.60M | $507.10M | $500.90M | $506.70M | $660.60M | $674.60M | $654.20M | $669.20M | $720.20M | $667.60M | $697.40M | $734.80M | $825.90M | $826.50M |
| QoQ Change | — | -0.4% | +315.7% | +4.9% | -3.0% | -4.2% | -0.6% | +0.3% | -1.2% | +1.2% | +30.4% | +2.1% | -3.0% | +2.3% | +7.6% | -7.3% | +4.5% | +5.4% | +12.4% | +0.1% |
| YoY Change | — | — | — | — | +321.5% | +305.4% | -3.0% | -7.3% | -5.6% | -0.3% | +30.7% | +33.0% | +30.6% | +32.1% | +9.0% | -1.0% | +6.6% | +9.8% | +14.7% | +23.8% |